BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29879499)

  • 1. Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.
    Balashova N; Giannakakis A; Brown AC; Koufos E; Benz R; Arakawa T; Tang HY; Lally ET
    Gene; 2018 Sep; 672():106-114. PubMed ID: 29879499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans.
    Sampathkumar V; Velusamy SK; Godboley D; Fine DH
    Sci Rep; 2017 May; 7(1):1887. PubMed ID: 28507341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Extracellular Domain of the β
    Ristow LC; Tran V; Schwartz KJ; Pankratz L; Mehle A; Sauer JD; Welch RA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains.
    Fong KP; Tang HY; Brown AC; Kieba IR; Speicher DW; Boesze-Battaglia K; Lally ET
    Mol Oral Microbiol; 2011 Aug; 26(4):262-76. PubMed ID: 21729247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.
    Balashova NV; Shah C; Patel JK; Megalla S; Kachlany SC
    Gene; 2009 Aug; 443(1-2):42-7. PubMed ID: 19450669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechin-mediated restructuring of a bacterial toxin inhibits activity.
    Chang EH; Huang J; Lin Z; Brown AC
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):191-198. PubMed ID: 30342156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains.
    Brogan JM; Lally ET; Poulsen K; Kilian M; Demuth DR
    Infect Immun; 1994 Feb; 62(2):501-8. PubMed ID: 8300209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
    Kachlany SC
    J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments.
    Velusamy SK; Sampathkumar V; Godboley D; Fine DH
    PLoS One; 2016; 11(3):e0151361. PubMed ID: 26977924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans.
    Diaz R; Ghofaily LA; Patel J; Balashova NV; Freitas AC; Labib I; Kachlany SC
    Microb Pathog; 2006 Feb; 40(2):48-55. PubMed ID: 16414241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.
    Brown AC; Boesze-Battaglia K; Balashova NV; Mas Gómez N; Speicher K; Tang HY; Duszyk ME; Lally ET
    PLoS One; 2018; 13(10):e0205871. PubMed ID: 30335797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.
    Krueger E; Brown AC
    Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Vega BA; Belinka BA; Kachlany SC
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454891
    [No Abstract]   [Full Text] [Related]  

  • 14. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
    Crosby JA; Kachlany SC
    Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells.
    Lally ET; Golub EE; Kieba IR
    J Biol Chem; 1994 Dec; 269(49):31289-95. PubMed ID: 7983074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans.
    Kachlany SC; Fine DH; Figurski DH
    Protein Expr Purif; 2002 Aug; 25(3):465-71. PubMed ID: 12182827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cranberry Proanthocyanidins Neutralize the Effects of
    Ben Lagha A; Howell A; Grenier D
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
    [No Abstract]   [Full Text] [Related]  

  • 19. Receptor-Based Peptides for Inhibition of Leukotoxin Activity.
    Krueger E; Hayes S; Chang EH; Yutuc S; Brown AC
    ACS Infect Dis; 2018 Jul; 4(7):1073-1081. PubMed ID: 29742342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.
    Brown AC; Balashova NV; Epand RM; Epand RF; Bragin A; Kachlany SC; Walters MJ; Du Y; Boesze-Battaglia K; Lally ET
    J Biol Chem; 2013 Aug; 288(32):23607-21. PubMed ID: 23792963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.